Next Article in Journal / Special Issue
Synthesis, Properties, and Electrochemistry of bis(iminophosphorane)pyridine Iron(II) Pincer Complexes
Previous Article in Journal
Functionalization of Na2Ca2Si3O9/Ca8Si5O18 Nanostructures with Chitosan and Terephthalaldehyde Crosslinked Chitosan for Effective Elimination of Pb(II) Ions from Aqueous Media
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis, Spectral Characterization, and Structural Modelling of Di- and Trinuclear Iron(III) Monensinates with Different Bridging Patterns

1
Faculty of Chemistry and Pharmacy, Sofia University St. Kliment Ohridski, 1164 Sofia, Bulgaria
2
Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria
3
Institute of Catalysis, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria
4
Institute of General and Inorganic Chemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria
5
Research and Development Department, Biovet Ltd., 4550 Peshtera, Bulgaria
*
Authors to whom correspondence should be addressed.
Inorganics 2024, 12(4), 114; https://doi.org/10.3390/inorganics12040114
Submission received: 18 March 2024 / Revised: 8 April 2024 / Accepted: 11 April 2024 / Published: 15 April 2024
(This article belongs to the Special Issue Metal Complexes Diversity: Synthesis, Conformations, and Bioactivity)

Abstract

:
In the present study, we report the solid-state isolation and structural characterization of novel iron(III) complexes of the veterinary antibiotic monensin. Monensic acid (MonH × H2O) forms a dinuclear complex of composition with FeCl3 [FeCl(Mon)2]2 (1), while its interaction with FeSO4 leads to the isolation of a triangular oxo-ferric coordination species [Fe3O(Mon × H2O)6(H2O)2(OH)] (2). During the procedure resulting in 2, oxidation of the Fe(II) ions by atmospheric oxygen was observed. In the presence of organic bases, both complexation reactions proceeded to successfully deprotonate the carboxylic function of the ligand. Iron(III) complexes 1 and 2 were characterized by IR, EPR, NMR, and Mössbauer spectroscopies as well as with thermal (TG-DTA/MS) and elemental analyses. In addition, the structures of the two coordination compounds were modelled and selected calculated parameters were compared with the experimental results. The biological assay revealed the enhanced antibacterial potential of the newly obtained complexes against the Gram-positive aerobic microorganisms Bacillus cereus and Bacillus subtilis.

Graphical Abstract

1. Introduction

Iron ions play a significant role in almost all living organisms [1]. They are vital for transporting oxygen, activating various substrates, and assisting in electron transfer reactions. Most of these processes occur due to the versatile coordination ability of both Fe(II) and Fe(III). The chemistry and biochemistry of ferric complexes are well known and have been subject to intensive reviewing over the years [2,3,4,5]. Iron(III) can form a wide variety of structural arrangements ranging from mono- to polynuclear coordination species with ligands involving diverse donor atoms and exhibiting different denticity. The literature overview reveals that a number of iron(III) complexes contain carboxylate ligands and exist as di- or trinuclear coordination species. In the first category, the carboxylate group participates as a terminal ligand in the formation of diamond-core Fe22-O)2 complexes with hydroxide/alkoxide bridges or acts as a (µ-η11)-link in both symmetric and asymmetric di-iron species [6,7,8,9,10,11,12,13,14,15,16]. Although rare, acetate complexes of various metal ions containing µ2-aqua or µ2-alcohol linkers are also known [17,18,19,20,21,22,23,24,25]. The trinuclear iron(III) carboxylates can be found mainly as oxo-ferric complexes adopting the typical triangular acetate structure [26,27,28,29]. In the above-mentioned constructs, three types of carboxylate coordination modes with respect to the isolated iron centre can be realised (Figure 1), excluding the pure metal–ligand ionic bond: monodentate, bidentate, and bridging [30,31]. Which configuration will prevail in the corresponding coordination species depends on many factors such as the overall ligand structure (i.e., the presence of other functional groups), the reaction conditions, the solvent effect, the metal salt counterion, etc.
In addition to the rich and diverse coordination chemistry of iron that makes it suitable for a large variety of functions within biological systems [32], its metabolism was found to be crucial also for the life cycle of cancer cells, triggering ferroptosis—a recently described form of regulated cell death caused by iron-dependent lipid peroxidation [33]. The ferroptosis is driven by various mechanisms, including the following:
(i)
glutathione level reduction and decreased activity of glutathione peroxidase, which results in the deposition of harmful lipid-reactive oxygen species (L-ROS) from polyunsaturated fatty acids in the presence of high concentrations of iron ions, thus promoting cell death [34];
(ii)
overexpression of transferrin receptor 1 (TFR1) and decrease in ferritin levels, since the upregulation of TFR1 is detected in many malformations such as glioblastoma, leukaemia, breast cancer, ovarian cancer, hepatic cancer, thyroid cancer, and colorectal cancer [35];
(iii)
Fenton reaction that strongly depends on the intracellular iron concentration and can be a possible mechanism of ROS generation.
Ferroptosis has been suggested to be an endogenous anticancer mechanism providing new opportunities in the treatment of drug-resistant tumours. In this sense, any natural compound that can induce such regulated cell death can be treated as a potential anticancer agent [36,37]. Recently, it was shown that some members of the natural carboxylic polyether ionophores—salinomycin and ironomycin—accumulate in lysosomes, sequester the lysosomal iron, and produce ROS in this organelle via Fenton reaction [38,39,40].
To gain deeper insight into the possible chemical interactions between polyether ionophores and Fe(II)/Fe(III), we initiated targeted research on the coordination ability of monensin and salinomycin (HL) to bind iron. Monensic acid (MonH, Figure S1) was selected as the most widely applied antibiotic in veterinary medicine, and salinomycinic acid (SalH) was deemed as a promising anticancer agent. Our first findings led to the isolation and characterization of iron(III) monensinate and salinomycinate of composition [Fe33–O)L3(OH)4] [41]. Then, under completely different reaction conditions, two new Fe(III) coordination compounds of monensin were obtained with the involvement of the antibiotic carboxylate function in the complex formation. The reported iron(III) complexes of monensin can be described as dinuclear chloro-containing (1) and trinuclear oxo-ferric (2) coordination species. The experimental data reveal that the antibiotic ligand serves in a pure monodentate/bidentate or in a bridged bidentate coordination mode, with the involvement of a terminal alcohol group in the bidentate ones. Employing the experimental and theoretical chemistry tools, we were able to derive reliable structures of these new iron(III) monensinates, combining various spectroscopies and the computational DFT method.

2. Results and Discussion

2.1. General Remarks

In the presence of organic bases (Et4NOH or Et3N), monensic acid effectively deprotonates and acts as a carboxylate monoanion in complexation reactions with metal ions of different oxidation states [41,42,43,44,45]. Monensinate reaction with FeCl3 or FeSO4 leads to the formation of new complexes which exhibit spectral properties characteristic of di- (1) and trinuclear (2) coordination species of iron(III), respectively. In addition, the formation of 1 is accompanied by co-precipitation of the mono-complex 1a (Figure S2). The complete set of experimental data is significantly different from that previously reported for iron(III) monensinate and salinomycinate [41], a fact indicating that we have prepared new ferric coordination compounds of the polyether ionophore monensin. The isolated solids 1 and 2 are amorphous without any sign of crystallinity, making their precise characterization difficult. The research methodology for structure elucidation described below is based on a series of spectroscopic techniques along with an appropriate computational chemistry protocol.

2.2. Physicochemical Properties of Complexes 1 and 2

2.2.1. Vibrational and Thermal Analysis

The IR spectra of 1 and 2 (Figure 2) reveal the deprotonation of monensin during its reaction with iron ions. The band of MonH × H2O at 1710 cm−1 assigned to the carboxylic group is replaced by two new bands at 1592 and 1419 cm−1 in the spectrum of 1, attributed to the corresponding asymmetric and symmetric stretching vibrations of the carboxylate function. The multicomponent band at 1592 cm−1 was fitted with three Lorentzians (inset in Figure 1) thus assuming different coordination modes of the carboxylate moiety in the solid sample of complex 1 [46]. The areas of the sub-bands (1) at 1594 cm−1 (FWHM = 66 cm−1) and (2) at 1554 cm−1 (FWHM = 46 cm−1) are almost equal (ca. 45% for each component), whereas the area of sub-band (3) is noticeably smaller. It is supposed that 1 comprises two main types of carboxylates whose ligation varies to some extent due to the different values of Δ = νasym − νsym, 175, and 135 cm−1, respectively. The weak band at 1643 cm−1 (FWHM = 75 cm−1, Δ = 224 cm−1) is attributed to the presence of monensinate bound in another type of complex species. The latter probably exists as an impurity in the solid sample rather than as a constituent of the intrinsic structure of 1. As will be described further, this assumption is supported by the magnetic studies used for structural characterization of 1.
The spectrum of 2 also consists of two bands at 1527 and 1417 cm−1, but the significantly smaller value of Δ = 110 cm−1 points to a bridging coordination mode of the carboxylate moiety. Complex 2 exhibits intense characteristic bands below 1000 cm−1 which are absent in 1. These vibrations are assigned to the formation of Fe-OH (δFeOH = 1047 cm−1) and Fe-O (νFeO = 430 cm−1) bonds, respectively. The bands in the range 4000–3000 cm−1, related to asymmetric and symmetric stretching vibrations of OH-bonds in the water molecule (3530–3460 cm−1), and νOH (3336 cm−1) in MonH × H2O, broaden in the spectra of 1 and 2 (3450–3470 cm−1) due to the OH-group’s engagement in various intramolecular interactions.
No intense endothermic peaks below 185 °C were observed in the TG-DTA/TG-MS curves of complex 1 (Figure S3a), ruling out the presence of coordinated water molecule(s). In contrast, the endothermic peak at 104 °C in 2 refers to a two-step water loss, which is an indication of different types of water molecules present in the studied sample (Figure S3b).
Based on the IR and thermal data, combined with microanalysis results, it can be concluded that (i) monensin is bound as a monoanion in the structures of 1 and 2; (ii) the molar metal-to-antibiotic ratio is 1:2 in both complexes; (iii) species 1 contains additional chloride ions, whereas a hydroxide anion and water ligands participate in the composition of 2.

2.2.2. Magnetic Studies

The EPR spectra of complexes 12 are registered in the temperature range from 77 K (100 K) to 295 K (Figure 3). A general characteristic of the spectra at r. t. is the broad signal with g = 2.02, attributable to iron(III) ions, confirming the oxidation of Fe(II) under atmospheric conditions during the preparation procedure of 2.
The peak-to-peak linewidth and intensity of the central signal (g = 2.02) in 12 show a well-defined tendency towards signal broadening with temperature decrease. Such a temperature dependence of the linewidth relates to an antiferromagnetic spin interaction of the metal centres, which becomes stronger at low temperatures.
The relatively broad signal with g = 2.02 observed for 1 is attributed to magnetically coupled Fe(III) ions [47]. It is accompanied by several extra signals which can be seen even at room temperature with effective g-factor values ranging from 28.64 to 1.61, labelled on Figure 3a. As the temperature decreases, the spectrum of 1 undergoes a transformation in which the less pronounced set of signals turns narrower at 100 K and becomes the main feature of the low temperature spectrum. On the other hand, the temperature behaviour of the signal with g = 2.02 is reversed. The result is that at 100 K its intensity is negligible compared with the intensities of the narrower lines set. Such a central field signal broadening can be attributed to the presence of closely spaced iron ions bound by a suitable ligand. Based on the composition data, we assume that chloride anions or hydroxyl groups of the monensinate may play the role of such a linker between two metal centres to witness the observed EPR behaviour of 1.
The set of lines that dominates the low-temperature spectrum of sample 1 refers to the fine structure of Fe3+ ions and its origin can be explained by allowed transitions with Δms = 1, although the existence of forbidden transition lines cannot be excluded either. These signals are ascribed to isolated Fe(III) ions placed in an axial symmetry field [48] and their presence can be attributed to the formation of the mono-complex 1a, whose composition and structure will be discussed later. We could not eliminate 1a despite our numerous attempts to purify the dinuclear complex. The presence of the assumed mono-species 1a does not affect the overall elemental composition of 1. The results are consistent with the IR-data, where the third weak band attributable to the asymmetric stretching of COO− is assigned to the formation of a second type of coordination species present in a minor quantity.
For sample 2 the signal at g = 2.02 is the main spectral characteristic over the entire temperature range. The g-factor value remains constant in the whole temperature span (Figure 3b). The negative Curie–Weiss constant (−608 ± 12 K) and the signal broadening at low temperatures (95 mT at 295 K and 142 mT at 77 K) indicate the occurrence of exchange-coupled iron(III) ions.
To obtain additional information on the binding mode of monensin in 12, we also performed NMR analysis, which might be strongly affected by the presence of paramagnetic ions, but in some cases can contribute to a deeper understanding of the properties of the metal complexes. We were unable to adjust the NMR settings and record any spectra of complex 2 using conventional NMR techniques, which may serve as indirect evidence that the studied monensinate sample contains paramagnetic iron(III) cations.
To our surprise, we recorded r. t. NMR spectra of 1 in CDCl3 to observe a negligible shift of the 13C signals compared with those of the uncoordinated monensic acid (Table S1) at low sample concentration, while augmenting the concentration resulted in a significant signal broadening. We hypothesized that a possible dissociation of the dinuclear iron(III) complex may occur, inflicting structure breakdown under the solvent action [49]. To confirm this, we also measured the EPR spectrum of the same solution at 120 K (Figure 4). Experimental results reveal that there are relatively narrow signals (ca. 15–20 mT) with g = 4.33 and 2.01, which can be attributed to isolated Fe3+ ions placed in a low and in an octahedral symmetry, respectively [50]. The hump detected at 240 mT (as part of a broad signal with g = 2.02) is attributed to the presence of exchange-coupled Fe(III) ions. EPR data recorded both in solution and in the solid state confirm that 1 comprises different types of coordination species. At the current stage of research, we cannot explain the negligible effect of Fe(III) on monensin NMR signals, but it may be related to the lability/inertness of the coordination species formed—a phenomenon that deserves further investigation, which is beyond the scope of the present study.

2.2.3. Mössbauer Studies

Monensin, as a representative of natural polyether ionophorous antibiotics, contains only O-donor atoms, so we suppose that the iron ions involved in the composition of complexes 1 and 2 will retain the high-spin configuration. Our hypothesis is confirmed by the subsequent Mössbauer studies performed at both room and liquid nitrogen temperatures.
The Mössbauer spectrum of 1 at 293 K consists of two asymmetric quadrupole signals that can be assigned to a minimum of two different types of iron ions. Consistent with the EPR data suggesting the presence of di- and mono-species, we decomposed the observed signals into three components by the least-squares fitting procedure (Figure 5a). Calculations reveal that two of the doublets (in 1:1 ratio, sub-spectra (1) and (2)) exhibit very close isomer shifts (IS, δ = ca. 0.4 mm/s) and quadrupole splittings (QS, Δ = ca. 0.7 mm/s) (Table 1). The results are consistent with the presence of high-spin iron(III) ions placed in a nearly identical octahedral environment [51] and corroborate previously reported data for ferric dimers containing two OH-bridges [52,53]. The minor sub-spectrum (3) differs from the rest, especially in the IS value. The doublet is assigned to the presence of mono-complex 1a and its low intensity agrees well with the IR and EPR data recorded. It can be concluded that Fe(III) in 1a is placed in a ligand environment similar to that of 1, as no significant change in its QS value is observed.
The Mössbauer spectrum of 2 at 293 K (Figure 5b) can be fitted in two doublets with similar IS values and 2:1 area, revealing the presence of three high-spin iron(III) ions bound in an octahedral crystal field. The QS values show that one of the metal centres is placed in a less symmetric environment than the other two. When this is compared with complex 1, and relying on Mössbauer/EPR studies performed, it can be assumed that coordination species 2 probably belongs to the triangular iron(III) complexes of the “acetate” type, where the carboxylate groups of the antibiotic are the “main characters” in the structure formed. The formation of mixed-valence Fe(II)-Fe(III) coordination species in the case of complex 2 is ruled out due to the absence of Mössbauer signals with high IS-values (>1.2 mm/s), thus directly confirming the full oxidation of Fe(II) ions under atmospheric conditions [54,55].
The increase in the isomer shift of both complexes at liquid nitrogen temperature is due to the second-order Doppler effect [56] (Figure S4). The quadrupole splitting, as expected for high-spin iron(III), does not exhibit an important temperature dependence. The average linewidth of all doublets (ca. 0.43 mm/s at 293 K and ca. 0.41 mm/s at 77 K) confirms the amorphous nature of the studied complex species.

2.2.4. Proposed Structures of Complexes 12

Based on the collected experimental data, we suggest that the isolated complex 1 represents a dinuclear iron(III) complex of monensin. Taking into account its composition (Fe3+:Cl:Mon = 1:1:2) and the observed spectral results, viable architectures can be constructed as follows:
(i)
two monensinates are bound to each iron(III) ion in a bidentate manner through their terminal carboxylate and hydroxyl functions, and two chloride anions link the metal centres (Figure 6a);
(ii)
two bidentate monensinate ligands bridge the iron ions via tail hydroxyl groups and each chloride anion is terminally bound to the metal cation (Figure 6b);
(iii)
the presence of a carboxylate linker as a structural motif in 1 is excluded due to the higher Δ-value(s) detected in the IR-spectra of the solid complex.
The formation of either construct (Figure 6) can explain the observed magnetic behaviour of 1, but to determine its most reliable structure, we applied a computational approach as described in Section 3.3.
Using the structures proposed above, we also assume that the isolation of 1 in solid state is accompanied by the presence of another type of coordination species, where the monensinate anion is bound in a similar fashion. This compound is deemed to be the mono-complex 1a of composition [FeCl(Mon)2] (Figure S2) which subsists in equilibrium with the dinuclear parent complex [FeCl(Mon)2]2. Its co-precipitation cannot be controlled, but obviously its formation corroborates the observed experimental EPR and Mössbauer data, especially at low temperatures.
The spectral and microanalysis results reveal that complex 2 most likely belongs to the group of the trinuclear oxo-ferric-monocarboxylates with composition [Fe33-O)(Mon × H2O)6(H2O)2(OH)] (Figure 7). We infer that each pair of ionophores serve as bridges between each pair of metal centres through the carboxylate function in a similar way to the known structure of ferric acetate. Binding of a hydroxide anion ensures the overall neutral character of the species formed. The magnetic data disclose the antiferromagnetic properties of 2, which may arise in an indirect manner, i.e., through an oxo-anion placed into the core of a trinuclear iron(III) cluster.
To elucidate the architecture of the first coordination sphere of species 12, we conducted an additional molecular modelling. As will be seen, the computed structural parameters are consistent with those observed experimentally, thus confirming the plausibility of the hypothesized constructs.

2.3. Theoretical Studies

2.3.1. Molecular Modelling of 1

To understand the intrinsic properties of complex 1, we built four dinuclear constructs with Ci point group symmetry as shown in Figure 8, where the monensinate binding was modelled by four acetates (representing its “head” carboxylate functions) and four ethanol molecules (as avatars of the “tail” segment hydroxyl groups). The chloride position was either bridging (1A) or terminal (1BD). Structure 1B comprises chloride anions which are perpendicular to the Fe2O6-chromophore and occupy the axial positions in the primary coordination shell. In the other two constructs the inorganic ions lie in the plane of the diamond-core, but the carboxylate groups are parallel (1C) and antiparallel (1D) to each other.
An indication of the preferred topology of 1 can be derived from the comparison between the calculated IR spectra for 1AD and the experimental one. A specific feature of the experimental spectrum is the splitting of the asymmetric C=O vibration into two bands with frequencies 1594 and 1554 cm−1 (Figure 2), which are a good match for the corresponding computed unscaled bands for 1BD (Table 2). In contrast, no splitting is found in the calculated vibrational spectrum of 1A—just a narrow band at 1613 cm−1. This is a sign that the dichloro-bridged structure 1A does not correspond to the experimentally observed vibrational behaviour of complex 1.
In order to evaluate the impact of the spin state on the EPR properties of target complex 1, the possible states for the two high-spin Fe(III) ions (S5/2) are taken into account, allowing for the complex to have either a ferromagnetic high spin (HS, St = 10/2) or an antiferromagnetic singlet (AFMS, St = 0) coupling (Scheme S1a). For 1A (chloride-bridged) and 1B (hydroxyl-bridged with axial chlorides) constructs the HS state is slightly more stable. The temperature decrease would lead to a population increase in the HS state, leading to an increased intensity of the experimental EPR signal. In the remaining models with hydroxyl oxygen linking (1CD, equatorially placed chlorides), the calculated energy difference favours the low spin state at 293 K. At lower temperatures, the population of the LS state should increase and the intensity of the EPR signal should decrease with a tendency to disappear (EPR-silent state). In line with the experimental EPR data obtained (decrease in the signal at g = 2.02) we can conclude that complex 1 can be described as an alcohol-bridged dimer with terminally ligated chloride anions 1CD [57].
The comparison between the anticipated and observed properties of all modelled structures discloses that those with equatorial chlorides are the most likely. The calculated Boltzmann distribution curves show 99.80% at 293 K and 100% at 77 K in favour of 1D over 1C. Thus, it can be summarized that the alcohol-bridged dimer with antiparallel orientation of the carboxylates (1D) is the most feasible model matching the structure of complex 1.

2.3.2. Molecular Design of 2

As a starting construct to design the primary coordination shell of complex 2, the crystal structure of ferric acetate [29] was used by replacing one of the water molecules with a hydroxide anion (Figure 9). The model consists of three high-spin iron ions which can interact with each other in different ways. We performed a full geometry optimization of the possible multiplicities—high spin (HS, St = 15/2) and antiferromagnetic sextet (AFMSx, St = 5/2); the spin alignments are presented in Scheme S1b. The modelled structure belongs to the C2v symmetry point group, where two of the iron ions are equivalent with respect to the principal symmetry axis and the corresponding plane containing it. Considering the energy dependence of the spin-flip position (Table 3), the predominantly populated AFMSx is the one in which the spins flip on the iron lying on C2 (ca. 123 kcal/mol). The state population at 293 and 77 K is calculated to be 82.9% of AFMSx (17.1% of HS) at 293 K and increases to 99.8% at 77 K.
To gain a deeper insight into the intimate properties of complex 2, an additional g-factor calculation was performed (Table 3), which matches well with the experimental findings (Figure 3b). The calculated value of the asymmetric C=O vibration (Table 2) is also in good agreement with the observed one.

2.4. Antibacterial Activity

The biological activity of MonH × H2O and complexes 12 is evaluated in terms of their minimum inhibitory concentration (MIC), at which the tested compounds effectively inhibit the visible growth of the target Gram-positive microorganisms. In the currently applied protocol conditions, B. cereus (BC) appears to be more sensitive to monensic acid compared with the B. subtilis strain (BS) (Table 4), while the parent salts FeCl3 × 6H2O and FeSO4 × 7H2O are ineffective below 3.6–3.7 mM against both bacterial strains and the same holds for the solvent used (methanol). The studied iron(III) complexes have four- (1) and six-fold (2) increased antibacterial efficacy against B. subtilis, which may be due to the presence of four and six antibiotic ligands in the composition of species 12, respectively. On the other hand, the new coordination species are eight (1) and twelve (2) times more potent in the case of B. cereus—an activity that cannot be explained in terms of a simple additive effect of metal cations and ligands, linked together in the complex structures. The observed enhanced bioactivity calls for further dedicated investigation of the efficacy of the newly obtained iron(III) monensinates against different target bacterial strains/cell lines to explore their potential as suitable bioactive metal-based drugs.

3. Experimental Section

3.1. Materials and Methods

Sodium monensinate (MonNa) was generously provided by Biovet Ltd. (Huvepharma, Peshtera, Bulgaria) in a chemically pure form and was used without further purification. Monensic acid monohydrate (MonH × H2O) was prepared by treating MonNa with HCl [58]. FeCl3 × 6H2O, FeSO4 × 7H2O, Et4NOH, Et3N, acetonitrile (MeCN), methanol (MeOH) p.a. grade, and CDCl3 were delivered by local suppliers. Deionized water was used in all experiments when necessary.
The following approaches and devices were utilized in the present study: infrared spectroscopy (IR) on a Nicolet 6700 FT-IR spectrometer (Thermo Scientific, Madison, WI, USA); thermogravimetry (TG-DTA, TG-MS) on a Setaram Labsys Evo 1600 (Caluire-et-Cuire, France); electron paramagnetic resonance (EPR) on a Bruker BioSpin EMXplus10/12 EPR spectrometer (Karlsruhe, Germany); nuclear magnetic resonance (NMR) on a Bruker NEO 600 spectrometer (Karlsruhe, Germany); 57Fe Mössbauer measurements on a Wissel spectrometer (Wissenschaftliche Elektronik GmbH, Starnberg, Germany); microanalysis on a Vario MACRO cube Elementar analysensysteme Gmbh (Stuttgart, Germany) (C, H) and Perkin-Elmer SCIEX-ELAN DRC-e ICP-MS (Massachusetts, USA) (Fe). Details of the technical parameters of the spectrometers and the corresponding sample preparation procedures are described in [41,59].

3.2. Synthesis of Complexes 12

Complex 1: To a solution of MonH × H2O (0.5 mmol, 344.45 mg in 15 mL MeCN), Et4NOH (0.5 mmol, 180 µL, 40% in H2O) was added. The reaction mixture was stirred for 15 min to ensure the deprotonation of the antibiotic and FeCl3 × 6H2O (0.17 mmol, 45.00 mg in 5 MeCN) was gradually added to spontaneously form an ochre solid phase. The precipitate was filtered off, washed with MeCN, and dried in a desiccator. [Fe2Cl2(Mon)4]: C144H244Cl2Fe2O44, MW 2862.08 g/mol. Calc. H, 8.89; C, 60.43; Cl, 2.48; Fe, 3.90%. Found: H, 8.19; C, 60.64; Cl, 2.16; Fe, 3.07%. Yield: 153.50 mg, 63%.
Complex 2: To a solution containing MonH × H2O (0.5 mmol, 344.45 mg in 20 mL MeCN/MeOH) and Et3N (1.0 mmol, 139.5 µL), solid FeSO4 × 7H2O (0.5 mmol, 139 mg) was added. The reaction mixture was stirred for 30 min until the iron salt was completely dissolved to turn the colourless solution into a yellow mixture. Subsequent addition of water afforded the formation of dark green precipitates which changed colour to tile red/rusty brown within 10–15 min, indicating Fe(II) oxidation. The solid phase was filtered off, washed with water, and dried in a desiccator. [Fe3O(Mon × H2O)6(H2O)2(OH)]: C216H383Fe3O76, MW 4363.90 g/mol. Calc. H, 8.85; C, 59.45; Fe, 3.84%. Found: H, 9.68; C, 59.01; Fe, 3.94%. Yield: 327.35 mg, 90%.

3.3. Computational Protocol

The quantum chemical calculations were performed according to a previously published protocol [41]. Briefly, the geometries of all constructs were optimized with Becke’s three-parameter hybrid-exchange functional combined with the Lee-Yang-Parr correlation functional [60], and with Grimme D3 correction [61] for the dispersion interactions and the 6–31G(d) basis set. Vibrational frequencies analysis was performed to verify the minima of all structures. The optimization and the vibrational spectra calculations were carried out with the software package Gaussian 16 [62]. The magnetic properties and EPR parameters for each EPR-active spin state were computed using ORCA 5.0.3 [63] with the BHandHLYP functional [64,65,66] which has a higher percentage of exact Hartree–Fock exchange, the latter being of great importance for the proper estimation of the spin exchange interactions in the studied systems. The TZVP basis set of Ahlrichs and co-workers [67,68] was implemented for the ligands and the CP(PPP) basis set for the iron ions [69]. All calculations were performed in vacuo.

3.4. Antibacterial Assay

The double-layer agar hole diffusion method [70] was applied to evaluate the effect of the compounds of interest towards Gram-positive microorganisms. Two aerobic bacterial strains were used in the present study—B. subtilis (NBIMCC 1709) and B. cereus (NBIMCC 1085), supplied by the National Bank for Industrial Microorganisms and Cell Cultures (NBIMCC, Bulgaria). The antibacterial efficiency of MonH × H2O, complexes 12, and parent iron salts was assessed according to the protocol described in [41], replacing DMSO with MeOH as a solvent where necessary.

4. Conclusions

Two new iron(III) monensinates were synthesized and characterized via a variety of experimental methods, supplemented by molecular modelling. Common features of the obtained octahedral complexes are that (i) the monensinate ligands are bound to the iron ions via their carboxylate termini, and (ii) the ratio Fe:ligand is 1:2. However, the pattern of coordination differs. With the Fe(III) salt, an antiferromagnetic dinuclear complex is formed with metal ions also exchange-coupled by hydroxyl groups of the ligand, whereas with the Fe(II) salt a trinuclear oxo-ferric complex results, in which the iron ions, being fully oxidized by the atmospheric oxygen to Fe(III), are linked solely by the carboxylate ligand functions to form an antiferromagnetic sextet. The structure of the complexes was decoded by means of comparison between the computed characteristics of models corresponding to the elemental analysis data and the results measured with the employed experimental approaches. The antibacterial activity tests reveal that the complexes exhibit equal (against B. subtilis) or higher (against B. cereus) bioactivity, which indicates that the newly synthesized complexes may find a useful implementation as medication in the veterinary practice.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/inorganics12040114/s1: Figure S1: Structure of monensin; Figure S2: Proposed structure of mono-complex 1a; Table S1: 13C-NMR chemical shift (δ, ppm) of monensic acid and complex 1 in CDCl3 (Δ = δ1 − δMonH); Figure S3: TG-DTA/MS curves of (a) complex 1 and (b) complex 2; Figure S4: Mössbauer spectra at 77 K: (a) complex 1, (b) complex 2; Scheme S1. Electron configurations of the iron ions in (a) complex 1 and (b) complex 2.

Author Contributions

Conceptualization, N.P. and I.P.; methodology and analysis, N.P., A.T., S.S., Z.C.-Z., D.P., R.S. and R.K.; resources, P.D.; writing—original draft preparation, N.P., I.P. and A.T.; writing—review and editing, I.P. and A.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the European Union—NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, project SUMMIT BG-RRP-2.004-0008-C01 (№ 70-123-186).

Data Availability Statement

Data are available from the authors upon request.

Conflicts of Interest

Author Petar Dorkov is employed by the company Biovet Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Biovet Ltd. provided the material sodium monensinate (MonNa), but the company was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.

References

  1. Crichton, R.R.; Pierre, J.-L. Old iron, young copper: From Mars to Venus. BioMetals 2001, 14, 99–112. [Google Scholar] [CrossRef] [PubMed]
  2. Crichton, R. Iron Metabolism: From Molecular Mechanisms to Clinical Consequences, 4th ed.; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2016; ISBN 978-1-118-92561-4. [Google Scholar]
  3. Ward, R.J.; Crichton, R.R. Ironing Out the Brain. Metal Ions in Life Science; De Gruyter: Berlin, Germany, 2019. [Google Scholar] [CrossRef]
  4. Ward, R.J.; Dexter, D.T.; Crichton, R.R. Neurodegenerative diseases and therapeutic strategies using iron chelators. J. Trace Elem. Med. Biol. 2015, 31, 267–273. [Google Scholar] [CrossRef] [PubMed]
  5. Roemhild, K.; von Maltzahn, F.; Weiskirchen, R.; Knüchel, R.; von Stillfried, S.; Lammers, T. Iron metabolism: Pathophysiology and pharmacology. Trends Pharmacol. Sci. 2021, 48, 640–656. [Google Scholar] [CrossRef]
  6. Thich, J.A.; Ou, C.-C.; Powers, D.; Vasilious, B.; Mastropaolo, D.; Potenza, J.A.; Schugar, H.J. Molecular structure and magnetic properties of mu-dihydroxo-bis[2,6-pyridine dicarboxylato aquoiron(III)] and mu-dihydroxo-bis[4-hydroxo-2,6-pyridine dicarboxylato aquoiron(III)] tetrahydrate. J. Am. Chem. Soc. 1976, 98, 1425–1433. [Google Scholar] [CrossRef]
  7. Ou, C.-C.; Lalancette, R.A.; Potenza, J.A.; Schugar, H.J. Molecular structure and magnetic properties of mu-dihydroxo-bis[4-dimethylamino-2,6-pyridinedicarboxylatoaquo iron(III)] dihydrate, [(CH3)2NC7H2NO4(H2O)FeOH]2.2H2O. J. Am. Chem. Soc. 1978, 100, 2053–2057. [Google Scholar] [CrossRef]
  8. Kato, M.; Yamada, T.; Inagaki, T.; Mori, W.; Sakai, K.; Tsubomura, T.; Sato, M.; Yano, S. Structures and magnetic properties of iron(III) dinuclear complexes with alkoxo and carboxylato bridges. Inorg. Chem. 1995, 34, 2645–2651. [Google Scholar] [CrossRef]
  9. Norman, R.E.; Yan, S.; Que, L., Jr.; Backes, G.; Ling, J.; Sanders-Loehr, J.; Zhang, J.H.; O’Connor, C.J. (mu-Oxo)(mu-carboxylato) diiron(III) complexes with distinct iron sites. Consequences of the inequivalence and its relevance to dinuclear iron-oxo proteins. J. Am. Chem. Soc. 1990, 112, 1554–1562. [Google Scholar] [CrossRef]
  10. Trukhan, V.M.; Gritsenko, O.N.; Nordlander, E.; Shteinman, A.A. Design and synthesis of new models for diiron biosites. J. Inorg. Biochem. 2000, 79, 41–46. [Google Scholar] [CrossRef]
  11. Pardo, E.; Lloret, F.; Carrasco, R.; Muñoz, M.C.; Temporal-Sánchez, T.; Ruiz-García, R. Chemistry and reactivity of dinuclear iron oxamate complexes: Alkane oxidation with hydrogen peroxide catalysed by an oxo-bridged diiron(III) complex with amide and carboxylate ligation. Inorg. Chim. Acta 2004, 357, 2713–2720. [Google Scholar] [CrossRef]
  12. Romakh, V.B.; Therrien, B.; Labat, G.; Stoekli-Evans, H.; Shul’pin, G.B.; Süss-Fink, G. Dinuclear iron, ruthenium and cobalt complexes containing 1,4-dimethyl-1,4,7-triazacyclononane ligands as well as carboxylato and oxo or hydroxo bridges. Inorg. Chim. Acta 2006, 359, 3297–3051. [Google Scholar] [CrossRef]
  13. Do, L.H.; Lippard, S.J. Toward functional carboxylate-bridged diiron protein mimics: Achieving structural stability and con-formational flexibility using a macrocyclic ligand framework. J. Am. Chem. Soc. 2011, 133, 10568–105681. [Google Scholar] [CrossRef] [PubMed]
  14. Abe, K.; Sakiyama, S.; Nishida, T. Structural investigation of four dinuclear iron(III) complexes relevant to renal injuries. J. Comp. Chem. 2015, 14, 23–29. [Google Scholar] [CrossRef]
  15. Comba, P.; Daumann, L.; Lefebvre, J.; Linti, G.; Martin, B.; Straub, J.; Zessin, T. Mono- and dinuclear copper(II) and iron(III) complexes of a tetradentate bispidine-diacetate ligand. Aust. J. Chem. 2009, 62, 1238–1245. [Google Scholar] [CrossRef]
  16. Paredes-García, V.; Latorre, R.O.; Spodine, E. Electronic and magnetic properties of iron(III) dinuclear complexes with carbox-ylate bridges. Polyhedron 2014, 23, 1869–1876. [Google Scholar] [CrossRef]
  17. Bell, M.; Edwards, A.J.; Hoskins, B.F.; Kachab, E.H.; Robson, R. Synthesis and crystal structure of a complex of a tetranucleating macrocyclic ligand which binds four NiII ions in a square arrangement with a µ4-hydroxo group at the centre. J. Chem. Soc. Chem. Commun. 1987, 24, 1852–1854. [Google Scholar] [CrossRef]
  18. Starosta, W.; Ptasiewicz-Bak, H.; Leciejewicz, J. The crystal and molecular structure of a new calcium(II) complex with pyri-dine-2,6-dicarboxylate, water and nitrate ligands. J. Coord. Chem. 2002, 55, 1147–1153. [Google Scholar] [CrossRef]
  19. Chen, Z.-Q.; Zhang, W.-Z.; Xu, Q. Poly[[mu]2-aqua-[[mu]2-1,1’-(butane-1,4-di yl) diimidazole] bis ([mu]4-naphthalene-1,4-dicarboxyl ato) dimanganese(II)]. Acta Cryst. Sect. E Struct. Rep. Online 2008, 64, m1543. [Google Scholar] [CrossRef] [PubMed]
  20. Shen, X.-Q.; Yao, H.-C.; Yang, R.; Li, Z.-J.; Zhang, H.-Y.; Wu, B.-L.; Hou, H.-W. Synthesis, structure and thermal properties of polynuclear complexes with a new multidentate ligand, N,N′-bis(5-ethyl-1,3,4-thiadiazol-2-yl)-2,6-pyridinedicarboxamide. Polyhedron 2008, 27, 203–209. [Google Scholar] [CrossRef]
  21. Azadmeher, A.; Amini, M.M.; Hadipour, N.; Khavasi, H.R.; Fun, H.-K.; Chen, C.-J. Synthesis and structural characterization of diorganotin(IV) complexes with 2,6-pyridinedicarboxylic acid. Appl. Organomet. Chem. 2008, 22, 19–24. [Google Scholar] [CrossRef]
  22. Su, Q.-J.; Li, S.-H.; Wang, L.; Xie, C.-Z.; Ouyang, Y.; Xu, J.-Y. Synthesis, structure and characterization of 1D threefold-bridging copper(II) chain with strong ferromagnetic coupling. Inorg. Chem. Comm. 2010, 13, 1210–1212. [Google Scholar] [CrossRef]
  23. White, N.G.; Kitchen, J.A.; Joule, J.A.; Brooker, S. Copper-induced N–N bond cleavage results in an octanuclear expanded-core grid-like complex. Chem. Commun. 2012, 48, 6229–6231. [Google Scholar] [CrossRef] [PubMed]
  24. Chen, M.; Sanudo, E.C.; Hu, J.-Y.; Hu, M.; Fang, S.-M.; Liu, C.-S. Structural diversity and magnetic properties of five Cu(II) complexes with mixed naphthalene-based dicarboxyl tecton and different N-donor co-ligands. Aust. J. Chem. 2013, 66, 963–971. [Google Scholar] [CrossRef]
  25. Gou, L.; Zhang, H.-X.; Fan, X.-Y.; Li, D.-L. Lithium based coordination polymer as anode for Li-ion battery. Inorg. Chim. Acta 2013, 394, 10–14. [Google Scholar] [CrossRef]
  26. Long, G.J.; Robinson, W.T.; Tappmeyer, W.P.; Bridges, D.L. The magnetic, electronic, and Mössbauer spectral properties of several trinuclear iron(III) carboxylate complexes. J. Chem. Soc. Dalton Trans. 1973, 6, 573–579. [Google Scholar] [CrossRef]
  27. Boudalis, A.K.; Sanakis, Y.; Raptopoulou, C.P.; Terzis, A.; Tuchagues, J.-P.; Perlepes, S.P. A trinuclear cluster containing the {Fe33-O)}7+ core: Structural, magnetic and spectroscopic (IR, Mössbauer, EPR) studies. Polyhedron 2005, 24, 1540–1548. [Google Scholar] [CrossRef]
  28. Kantouri, M.-L.; Papadopoulos, C.D.; Hatzidimitriou, A.G.; Bakas, T.; Pachini, S. A trinuclear iron(III) complex containing the semi-cubane [Fe33-O)]7+ core: Structural, spectroscopic, magnetic and electrochemical study. Z. Für Anorg. Und Allg. Chem. 2010, 636, 531–538. [Google Scholar] [CrossRef]
  29. Balić, T.; Jagličić, Z.; Sadrollah, E.; Litterst, F.J.; Počkaj, M.; Baabe, B.; Kovač-Andrić, E.; Bijelić, J.; Gašo-Sokač, D.; Djerdj, I. Single crystal growth, structural characterization and magnetic properties study of an antiferromagnetic trinuclear iron(III) acetate complex with uncoordinated hexamine. Inorg. Chim. Acta 2021, 520, 120292. [Google Scholar] [CrossRef]
  30. Bronstein, L.M.; Huang, X.; Retrum, J.; Schmucker, A.; Pink, M.; Stein, B.D.; Dragnea, B. Influence of iron oleate complex structure on iron oxide nanoparticle formation. Chem. Mater. 2007, 19, 3624–3632. [Google Scholar] [CrossRef]
  31. Lin, M.M.; Kim, D.K. In situ thermolysis of magnetic nanoparticles using non-hydrated iron oleate complex. J. Nanopart. Res. 2012, 14, 688. [Google Scholar] [CrossRef]
  32. Sánchez, M.; Sabio, L.; Gálvez, N.; Capdevila, M.; Dominguez-Vera, J.M. Iron chemistry at the service of life. IUBMB Life 2017, 69, 382–388. [Google Scholar] [CrossRef]
  33. Stockwell, B.R.; Jiang, X. The chemistry and biology of ferroptosis. Cell Chem. Biol. 2020, 27, 365–375. [Google Scholar] [CrossRef] [PubMed]
  34. Qiu, Y.; Cao, Y.; Cao, W.; Jia, Y.; Lu, N. The application of ferroptosis in diseases. Pharmacol. Res. 2020, 159, 104919. [Google Scholar] [CrossRef] [PubMed]
  35. Guo, Q.; Li, L.; Hou, S.; Yuan, Z.; Li, C.; Zhang, W.; Zheng, L.; Li, X. The role of iron in cancer progression. Front. Oncol. 2021, 11, 778492. [Google Scholar] [CrossRef] [PubMed]
  36. Wu, Z.; Zhong, M.; Liu, Y.; Xiong, Y.; Gao, Z.; Ma, J.; Zhuang, G.; Hong, X. Application of natural products for inducing ferroptosis in tumor cells. Biotechnol. Appl. Biochem. 2022, 69, 190–197. [Google Scholar] [CrossRef] [PubMed]
  37. Su, Y.; Zhao, B.; Zhou, L.; Zhang, Z.; Shen, Y.; Lv, H.; Al Qudsy, L.H.H.; Shang, P. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett. 2020, 483, 127–136. [Google Scholar] [CrossRef] [PubMed]
  38. Mai, T.T.; Hamaï, A.; Hienzsch, A.; Cañeque, T.; Müller, S.; Wicinski, J.; Cabaud, O.; Leroy, C.; David, A.; Acevedo, V.; et al. Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat. Chem. 2017, 9, 1025–1033. [Google Scholar] [CrossRef] [PubMed]
  39. Versini, A.; Colombeau, L.; Hienzch, A.; Gaillet, C.; Retailleau, P.; Debieu, S.; Müller, S.; Cañeque, T.; Rodriguez, R. Salinomycin derivatives kill breast cancer stem cells by lysosomal iron targeting. Chem.-Eur. J. 2020, 26, 7416–7424. [Google Scholar] [CrossRef] [PubMed]
  40. Antoszczak, M.; Müller, S.; Cañeque, T.; Colombeau, L.; Dusetti, N.; Santofimia-Castaño, P.; Gaillet, G.; Puisieux, A.; Iovanna, J.L.; Rodriguez, R. Iron-sensitive prodrugs that trigger active ferroptosis in drug-tolerant pancreatic cancer cells. J. Am. Chem. Soc. 2022, 144, 11536–11545. [Google Scholar] [CrossRef] [PubMed]
  41. Petkov, N.; Tadjer, A.; Encheva, E.; Cherkezova-Zheleva, Z.; Paneva, D.; Stoyanova, R.; Kukeva, R.; Dorkov, P.; Pantcheva, I. Experimental and DFT study of monensinate and salinomycinate complexes containing {Fe33–O)}7+ core. Molecules 2024, 26, 364. [Google Scholar] [CrossRef]
  42. Pantcheva, I.N.; Ivanova, J.; Zhorova, R.; Mitewa, M.; Simova, S.; Mayer-Figge, H.; Sheldrick, W.S. Nickel(II) and zinc(II) dim-onensinates: Crystal structure, spectral properties and bactericidal activity. Inorg. Chim. Acta 2010, 363, 1879–1886. [Google Scholar] [CrossRef]
  43. Ivanova, J.; Pantcheva, I.N.; Mitewa, M.; Simova, S.; Mayer-Figge, H.; Sheldrick, W.S. Crystal structures and spectral properties of new Cd(II) and Hg(II) complexes of monensic acid with different coordination modes of the ligand. Centr. Eur. J. Chem. 2010, 8, 852–860. [Google Scholar] [CrossRef]
  44. Pantcheva, I.; Dimitrova, R.; Nedzhib, A.; Dorkov, P.; Stoyanova, R.; Zhecheva, E. Coordination compounds of polyether ionophore Monensin with gadolinium(III) ions. In Nanoscience & Nanotechnology (Sofia); Balabanova, E., Mileva, E., Eds.; Acad. Evgeni Budevski Institute of Electrochemistry and Energy Systems (IEES-BAS), Bulgarian Academy of Sciences (BAS): Sofia, Bulgaria, 2019; Volume 19, pp. 40–46, ISSN 1313-8995 (print), ISSN 2738-8743 (online). [Google Scholar]
  45. Pantcheva, I.; Dimitrova, R.; Ivanova, V.; Nedzhib, A.; Dorkov, P.; Dinev, D.; Spasov, R.; Alexandrova, R. Spectral properties and biological activity of La(III) and Nd(III) monensinates. Open Chem. 2019, 17, 1423–1434. [Google Scholar] [CrossRef]
  46. Wojdyr, M. Fityk: A general-purpose peak fitting program. J. Appl. Crystallogr. 2010, 43, 1126–1128. [Google Scholar] [CrossRef]
  47. Muralidhara, R.S.; Kesavulu, C.R.; Rao, J.L.; Anavekar, R.V.; Chakradhar, R.P.S. EPR and optical absorption studies of Fe3+ ions in sodium borophosphate glasses. J. Phys. Chem. Solids 2010, 71, 1651–1655. [Google Scholar] [CrossRef]
  48. Kakazey, M.; Vlasova, M.; Gonzalez-Rodriguez, G.; Salazar-Hernández, B. Fine structure of EPR spectra of Fe3+ in α-Al2O3 crystal, powders, and textured ceramics. Mat. Sci. Engin. 2002, 90, 114–119. [Google Scholar] [CrossRef]
  49. Borer, L.; Thalken, L.; Zhang, J.H.; Reiff, W.M. Characterization of a dimeric iron(III) complex of N,N’-ethylenebis(salicylamine). Inorg. Chem. 1983, 22, 3174–3176. [Google Scholar] [CrossRef]
  50. Vercamer, V.; Lelong, G.; Hijiya, H.; Kondo, Y.; Galoisy, L.; Calas, G. Diluted Fe3+ in silicate glasses: Structural effects of Fe-redox state and matrix composition. An optical absorption and X-band/Q-band EPR study. J. Non-Cryst. Solids 2015, 428, 138–145. [Google Scholar] [CrossRef]
  51. Murray, K.S. Binuclear oxo-bridged iron(III) complexes. Coord. Chem. Rev. 1974, 12, 1–35. [Google Scholar] [CrossRef]
  52. Rodriguez, F.; Moreno, M. The influence of water addition on solutions of FeCl3 in isopropanol. Z. Für Naturforschung 1983, 38, 701–702. [Google Scholar] [CrossRef]
  53. Vertes, A.; Korecz, L.; Burger, K. Mössbauer Spectroscopy; Elsevier: Amsterdam, The Netherlands, 1979. [Google Scholar]
  54. Reedijk, J.; van Der Kraan, A.M. Mössbauer effect of octahedral iron(II) solvates. Recl. Trav. Chim. Pays-Bas. 1969, 88, 828–832. [Google Scholar] [CrossRef]
  55. Goldanskii, V.I.; Herber, R.H. Chemical Applications of Mossbauer Spectroscopy; Academic Press: Cambridge, MA, USA, 1968. [Google Scholar]
  56. Greenwood, N.N.; Gibb, T.C. Mössbauer Spectroscopy; Chapman and Hall: London, UK, 1971. [Google Scholar]
  57. You, Z.-L.; Zhu, H.-L. A dinuclear Schiff base iron(III) complex with the ligand N,N’-bis(2-oxidophenylmethyleneimino) pro-pane-1,2-diamine. Acta Cryst. Sect. E: Struct. Rep. Online 2004, 60, m1046–m1048. [Google Scholar] [CrossRef]
  58. Gertenbach, P.G.; Popov, A.I. Solution chemistry of monensin and its alkali metal ion complexes. Potentiometric and spec-troscopic studies. J. Am. Chem. Soc. 1975, 97, 4738–4744. [Google Scholar] [CrossRef]
  59. Petkov, N.; Pantcheva, I.; Ivanova, A.; Stoyanova, R.; Kukeva, R.; Alexandrova, R.; Abudalleh, A.; Dorkov, P. Novel cerium(IV) coordination compounds of monensin and salinomycin. Molecules 2023, 28, 4676. [Google Scholar] [CrossRef] [PubMed]
  60. Stephens, P.J.; Devlin, F.J.; Chabalowski, C.F.; Frisch, M.J. Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields. J. Phys. Chem. 1994, 98, 11623–11627. [Google Scholar] [CrossRef]
  61. Grimme, S.; Antony, J.; Ehrlich, S.; Krieg, H. A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu. J. Chem. Phys. 2010, 132, 154104. [Google Scholar] [CrossRef] [PubMed]
  62. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Petersson, G.A.; Nakatsuji, H.; et al. Gaussian 16, Revision B.01; GaussView 5.0.; Gaussian, Inc.: Wallingford, CT, USA, 2016. [Google Scholar]
  63. Neese, F. Software update: The ORCA program system—Version 5.0. WIREs Comp. Mol. Sci. 2022, 12, e1606. [Google Scholar] [CrossRef]
  64. Becke, A.D. A new mixing of Hartree-Fock and local density-functional theories. J. Chem. Phys. 1993, 98, 1372–1377. [Google Scholar] [CrossRef]
  65. Yang, Y.; Ratner, M.A.; Schatz, G.C. Computational modeling of octahedral iron oxide clusters: Hexaaquairon(III) and its dimers. J. Phys. Chem. C 2013, 117, 21706–21717. [Google Scholar] [CrossRef]
  66. Zhao, H.; Fang, C.; Gao, J.; Liu, C. Spin-state energies of heme-related models from spin-flip TDDFT calculations. Phys. Chem. Chem. Phys. 2016, 18, 29486–29494. [Google Scholar] [CrossRef]
  67. Schaefer, A.; Horn, H.; Ahlrichs, R. Fully optimized contracted Gaussian-basis sets for atoms Li to Kr. J. Chem. Phys. 1992, 97, 2571–2577. [Google Scholar] [CrossRef]
  68. Schaefer, A.; Huber, C.; Ahlrichs, R. Fully optimized contracted Gaussian-basis sets of triple zeta valence quality for atoms Li to Kr. J. Chem. Phys. 1994, 100, 5829–5835. [Google Scholar] [CrossRef]
  69. Neese, F. Prediction and interpretation of the 57Fe isomer shift in Mössbauer spectra by density functional theory. Inorg. Chim. Acta 2002, 337, 181–192. [Google Scholar] [CrossRef]
  70. Andrews, J.M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 2001, 48 (Suppl. S1), 5–16. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The possible (a) monodentate, (b) bidentate, and (c) bridging coordination patterns of the carboxylate group to iron(III) cation(s).
Figure 1. The possible (a) monodentate, (b) bidentate, and (c) bridging coordination patterns of the carboxylate group to iron(III) cation(s).
Inorganics 12 00114 g001
Figure 2. IR spectra of MonH × H2O and complexes 12 in KBr pellets.
Figure 2. IR spectra of MonH × H2O and complexes 12 in KBr pellets.
Inorganics 12 00114 g002
Figure 3. X-band solid-state EPR spectra of 1 (a) and 2 (b) registered in the range 77–293 K.
Figure 3. X-band solid-state EPR spectra of 1 (a) and 2 (b) registered in the range 77–293 K.
Inorganics 12 00114 g003
Figure 4. X-band EPR spectrum of frozen solution of 1 in CDCl3.
Figure 4. X-band EPR spectrum of frozen solution of 1 in CDCl3.
Inorganics 12 00114 g004
Figure 5. Mössbauer spectra at 293 K: (a) complex 1, (b) complex 2.
Figure 5. Mössbauer spectra at 293 K: (a) complex 1, (b) complex 2.
Inorganics 12 00114 g005
Figure 6. Proposed structure of complex 1 as dinuclear chloro-bridged (a) or hydroxyl-bridged (b) species. The monensinate skeleton is represented schematically by the dashed line connecting the terminal ligating groups.
Figure 6. Proposed structure of complex 1 as dinuclear chloro-bridged (a) or hydroxyl-bridged (b) species. The monensinate skeleton is represented schematically by the dashed line connecting the terminal ligating groups.
Inorganics 12 00114 g006
Figure 7. Proposed structure of the triangular oxo-complex 2 (R represents the polyether cavity hosting a water molecule).
Figure 7. Proposed structure of the triangular oxo-complex 2 (R represents the polyether cavity hosting a water molecule).
Inorganics 12 00114 g007
Figure 8. Modelled structures of ferric dimers 1 (AD). Hydrogens are omitted for clarity. Colour code: C—grey, O—red, Cl—green, Fe—orange.
Figure 8. Modelled structures of ferric dimers 1 (AD). Hydrogens are omitted for clarity. Colour code: C—grey, O—red, Cl—green, Fe—orange.
Inorganics 12 00114 g008
Figure 9. Modelled structure of complex 2. Hydrogens are omitted for clarity. Colour code: C—grey, O—red, Fe—orange. The hydroxide oxygen is presented in yellow.
Figure 9. Modelled structure of complex 2. Hydrogens are omitted for clarity. Colour code: C—grey, O—red, Fe—orange. The hydroxide oxygen is presented in yellow.
Inorganics 12 00114 g009
Table 1. Mössbauer parameters for solid samples 1 and 2 at 293 K (and 77 K in parentheses).
Table 1. Mössbauer parameters for solid samples 1 and 2 at 293 K (and 77 K in parentheses).
ComplexComponentδ, mm/sΔ, mm/sΓ, mm/sA, %M, %
1Db10.43 (0.60)0.75 (0.75)0.45 (0.45)47 (48)0.49 (1.48)
Db20.41 (0.61)0.74 (0.79)0.57 (0.52)45 (47)0.37 (1.29)
Db30.21 (0.40)0.82 (0.75)0.40 (0.40)8 (5)0.09 (0.19)
2Db10.37 (0.57)0.63 (0.62)0.32 (0.31)66 (64)6.96 (8.41)
Db20.39 (0.58)0.96 (1.00)0.42 (0.38)34 (36)2.99 (3.91)
Table 2. Frequencies of asymmetric stretches of the carboxylate function in monensin and similarity factors—SF (the ratio of the experimental to the calculated value for each pair of results).
Table 2. Frequencies of asymmetric stretches of the carboxylate function in monensin and similarity factors—SF (the ratio of the experimental to the calculated value for each pair of results).
ComplexBand Position, cm−1
Exp.Calc.SF
1A1613
1B (sub-band 1)159416470.97
1B (sub-band 2)155415780.98
1C (sub-band 1)159416260.98
1C (sub-band 2)155416040.97
1D (sub-band 1)159416550.96
1D (sub-band 2)155416070.97
2152716490.93
Table 3. Enthalpy difference and calculated g-factors for the states of the proposed construct of complex 2.
Table 3. Enthalpy difference and calculated g-factors for the states of the proposed construct of complex 2.
MultiplicityΔH, kcal/mol, 293 Kg-Factor, 0 K
HS0.912.005
AFMSx0.002.004
AFMSx-ooa *122.712.087
* Spin-flip is performed on the iron ion which does not lie on the principal axis.
Table 4. MIC of the polyether ionophore and its complexes 12.
Table 4. MIC of the polyether ionophore and its complexes 12.
Bacteria
Compound
MW, g/molBCBS
µg/mLµMµg/mLµM
MonH × H2O688.903.915.6715.6322.69
Complex 12862.081.950.6815.635.46
Complex 24363.901.950.4715.633.58
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Petkov, N.; Tadjer, A.; Simova, S.; Cherkezova-Zheleva, Z.; Paneva, D.; Stoyanova, R.; Kukeva, R.; Dorkov, P.; Pantcheva, I. Synthesis, Spectral Characterization, and Structural Modelling of Di- and Trinuclear Iron(III) Monensinates with Different Bridging Patterns. Inorganics 2024, 12, 114. https://doi.org/10.3390/inorganics12040114

AMA Style

Petkov N, Tadjer A, Simova S, Cherkezova-Zheleva Z, Paneva D, Stoyanova R, Kukeva R, Dorkov P, Pantcheva I. Synthesis, Spectral Characterization, and Structural Modelling of Di- and Trinuclear Iron(III) Monensinates with Different Bridging Patterns. Inorganics. 2024; 12(4):114. https://doi.org/10.3390/inorganics12040114

Chicago/Turabian Style

Petkov, Nikolay, Alia Tadjer, Svetlana Simova, Zara Cherkezova-Zheleva, Daniela Paneva, Radostina Stoyanova, Rositsa Kukeva, Petar Dorkov, and Ivayla Pantcheva. 2024. "Synthesis, Spectral Characterization, and Structural Modelling of Di- and Trinuclear Iron(III) Monensinates with Different Bridging Patterns" Inorganics 12, no. 4: 114. https://doi.org/10.3390/inorganics12040114

APA Style

Petkov, N., Tadjer, A., Simova, S., Cherkezova-Zheleva, Z., Paneva, D., Stoyanova, R., Kukeva, R., Dorkov, P., & Pantcheva, I. (2024). Synthesis, Spectral Characterization, and Structural Modelling of Di- and Trinuclear Iron(III) Monensinates with Different Bridging Patterns. Inorganics, 12(4), 114. https://doi.org/10.3390/inorganics12040114

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop